Pitfalls and Limitations of SPECT, PET, and Therapeutic Radiopharmaceuticals
- 1 September 2015
- journal article
- review article
- Published by Elsevier in Seminars in Nuclear Medicine
- Vol. 45 (5) , 470-478
Abstract
No abstract availableKeywords
This publication has 76 references indexed in Scilit:
- Guidance on current good radiopharmacy practice for the small‐scale preparation of radiopharmaceuticals using automated modules: a European perspectiveJournal of Labelled Compounds and Radiopharmaceuticals, 2014
- Evaluation of excitation functions of 100Mo(p,d+pn)99Mo and 100Mo (p,2n)99mTc reactions: Estimation of long-lived Tc-impurity and its implication on the specific activity of cyclotron-produced 99mTcApplied Radiation and Isotopes, 2014
- Influence of the Generator in-Growth Time on the Final Radiochemical Purity and Stability of RadiopharmaceuticalsScience and Technology of Nuclear Installations, 2013
- Effect of 99Tc on the radiochemical purity of 99mTc radiopharmaceuticalsNuclear Medicine Communications, 2011
- Equilibrium radionuclide angiocardiographyJournal of Nuclear Cardiology, 2006
- On the “artificial” nature of Tc and the “carrier-free” nature of 99mTc from 99Mo/99mTc generatorsApplied Radiation and Isotopes, 2005
- Radiopharmaceutical-related pitfalls and artifactsSeminars in Nuclear Medicine, 1996
- Effect of different anticoagulants on the labelling of red blood cells and plasma proteins with 99TcmNuclear Medicine Communications, 1994
- Radiochemical stability during infusion of 131I-labelled metaiodobenzylguanidine for therapeutic useNuclear Medicine Communications, 1993
- Formation of labelled colloid in 99Tcm-DMSA due to the presence of bactericidal fluidNuclear Medicine Communications, 1986